Unknown

Dataset Information

0

Phenome-wide association studies across large population cohorts support drug target validation.


ABSTRACT: Phenome-wide association studies (PheWAS) have been proposed as a possible aid in drug development through elucidating mechanisms of action, identifying alternative indications, or predicting adverse drug events (ADEs). Here, we select 25 single nucleotide polymorphisms (SNPs) linked through genome-wide association studies (GWAS) to 19 candidate drug targets for common disease indications. We interrogate these SNPs by PheWAS in four large cohorts with extensive health information (23andMe, UK Biobank, FINRISK, CHOP) for association with 1683 binary endpoints in up to 697,815 individuals and conduct meta-analyses for 145 mapped disease endpoints. Our analyses replicate 75% of known GWAS associations (P?

SUBMITTER: Diogo D 

PROVIDER: S-EPMC6191429 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7549611 | BioStudies
2013-01-01 | S-EPMC3969265 | BioStudies
2015-01-01 | S-EPMC4666492 | BioStudies
2016-01-01 | S-EPMC5035188 | BioStudies
2014-01-01 | S-EPMC3904236 | BioStudies
2016-01-01 | S-EPMC4718547 | BioStudies
2018-01-01 | S-EPMC5789733 | BioStudies
2015-01-01 | S-EPMC4661230 | BioStudies
2014-01-01 | S-EPMC4235428 | BioStudies
2013-01-01 | S-EPMC3561060 | BioStudies